Chong Xu

Chong Xu

Director/Board Member at K36 Therapeutics, Inc.

43 year
Finance
Health Technology
Consumer Services

Profile

Chong Xu is currently a Director at Geneception, Inc., K36 Therapeutics, Inc., Shanghai Rarestone Health Tech Group Co. Ltd., and Partner at Impresa Management LLC.
Previously, Dr. Xu worked as a Director at Adagene, Inc. from 2020 to 2021, an Equity Analyst at Massif Partners Holdings LP, an Associate at McKinsey & Co., Inc., an Analyst at Affirmed Capital LLC, and a Principal at Eight Roads Ventures Japan.
Dr. Xu holds a doctorate degree from the University of Virginia, an undergraduate degree from Zhejiang University, and an MBA from the University of Virginia Darden School of Business.

Chong Xu active positions

CompaniesPositionStart
Private Equity Investor -
Director/Board Member -
Director/Board Member -
Director/Board Member -
All active positions of Chong Xu

Former positions of Chong Xu

CompaniesPositionEnd
ADAGENE INC. Director/Board Member 2021-02-07
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Analyst-Equity -
See the detail of Chong Xu's experience

Training of Chong Xu

University of Virginia Doctorate Degree
Zhejiang University Undergraduate Degree
University of Virginia Darden School of Business Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Chong Xu's experience

Connections

100 +

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ADAGENE INC.

Health Technology

Private companies8

Finance

Finance

Commercial Services

Finance

Finance

Health Technology

Health Technology

Health Technology

See company connections